ZNTL Zentalis Pharmaceuticals | $4.14
-50.7% | 6/18/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $50.00 -> $25.00 | Low | View details for Oppenheimer rating of Zentalis Pharmaceuticals (NASDAQ:ZNTL) on 6/18/2024 |
ADSK Autodesk | $244.12
+1.5% | 6/18/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $275.00 -> $275.00 | Low | View details for Oppenheimer rating of Autodesk (NASDAQ:ADSK) on 6/18/2024 |
EDIT Editas Medicine | $5.04
-0.6% | 6/18/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | $12.00 -> $12.00 | Low | View details for Oppenheimer rating of Editas Medicine (NASDAQ:EDIT) on 6/18/2024 |
CATX Perspective Therapeutics | $11.93
+15.4% | 6/18/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | | Low | View details for Oppenheimer rating of Perspective Therapeutics (NYSE:CATX) on 6/18/2024 |
OVID Ovid Therapeutics | $0.79
| 6/18/2024 | Downgraded by | Oppenheimer | - | Outperform -> Market Perform | | Low | View details for Oppenheimer rating of Ovid Therapeutics (NASDAQ:OVID) on 6/18/2024 |
RNAC Cartesian Therapeutics | $21.76
-6.7% | 6/14/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $50.00 -> $50.00 | Low | View details for Oppenheimer rating of Cartesian Therapeutics (NASDAQ:RNAC) on 6/14/2024 |
|
URGN UroGen Pharma | $16.87
-7.7% | 6/14/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $32.00 -> $40.00 | Low | View details for Oppenheimer rating of UroGen Pharma (NASDAQ:URGN) on 6/14/2024 |
ADBE Adobe | $522.25
+0.7% | 6/14/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $580.00 -> $580.00 | Low | View details for Oppenheimer rating of Adobe (NASDAQ:ADBE) on 6/14/2024 |
B Barnes Group | $39.57
-0.7% | 6/14/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $43.00 -> $48.00 | Low | View details for Oppenheimer rating of Barnes Group (NYSE:B) on 6/14/2024 |
JEF Jefferies Financial Group | $46.51
+3.4% | 6/14/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $56.00 -> $57.00 | Low | View details for Oppenheimer rating of Jefferies Financial Group (NYSE:JEF) on 6/14/2024 |
APP AppLovin | $80.84
+3.0% | 6/13/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $97.00 -> $97.00 | Low | View details for Oppenheimer rating of AppLovin (NASDAQ:APP) on 6/13/2024 |
SLP Simulations Plus | $47.21
+0.4% | 6/13/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $55.00 -> $65.00 | Low | View details for Oppenheimer rating of Simulations Plus (NASDAQ:SLP) on 6/13/2024 |
AVGO Broadcom | $1,802.52
-1.4% | 6/13/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $1,500.00 -> $2,000.00 | Low | View details for Oppenheimer rating of Broadcom (NASDAQ:AVGO) on 6/13/2024 |
MPWR Monolithic Power Systems | $852.56
+3.0% | 6/13/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $750.00 -> $900.00 | Low | View details for Oppenheimer rating of Monolithic Power Systems (NASDAQ:MPWR) on 6/13/2024 |
SPRB Spruce Biosciences | $0.63
-3.1% | 6/13/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $4.00 -> $3.00 | Low | View details for Oppenheimer rating of Spruce Biosciences (NASDAQ:SPRB) on 6/13/2024 |
AGCO AGCO | $102.29
-0.4% | 6/12/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $145.00 -> $133.00 | Low | View details for Oppenheimer rating of AGCO (NYSE:AGCO) on 6/12/2024 |
MRNA Moderna | $133.27
-3.4% | 6/12/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $163.00 -> $179.00 | Low | View details for Oppenheimer rating of Moderna (NASDAQ:MRNA) on 6/12/2024 |
CLLS Cellectis | $2.03
-5.1% | 6/12/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $11.00 -> $10.00 | Low | View details for Oppenheimer rating of Cellectis (NASDAQ:CLLS) on 6/12/2024 |
ARMK Aramark | $33.80
+0.3% | 6/12/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $36.00 -> $39.00 | Low | View details for Oppenheimer rating of Aramark (NYSE:ARMK) on 6/12/2024 |
FSLR First Solar | $262.37
+0.4% | 6/12/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $271.00 -> $325.00 | Low | View details for Oppenheimer rating of First Solar (NASDAQ:FSLR) on 6/12/2024 |
BRZE Braze | $35.13
-0.8% | 6/12/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $60.00 -> $60.00 | Low | View details for Oppenheimer rating of Braze (NASDAQ:BRZE) on 6/12/2024 |
PERI Perion Network | $9.04
-3.2% | 6/10/2024 | Downgraded by | Oppenheimer | - | Outperform -> Market Perform | | Low | View details for Oppenheimer rating of Perion Network (NASDAQ:PERI) on 6/10/2024 |
GLTO Galecto | $0.49
-2.0% | 6/10/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $10.00 -> $9.00 | Low | View details for Oppenheimer rating of Galecto (NASDAQ:GLTO) on 6/10/2024 |
TNDM Tandem Diabetes Care | $42.83
-0.4% | 6/10/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $47.00 -> $58.00 | Low | View details for Oppenheimer rating of Tandem Diabetes Care (NASDAQ:TNDM) on 6/10/2024 |
MCRB Seres Therapeutics | $0.71
+6.0% | 6/7/2024 | Reiterated by | Oppenheimer | - | Outperform -> Market Perform | | Low | View details for Oppenheimer rating of Seres Therapeutics (NASDAQ:MCRB) on 6/7/2024 |
MSFT Microsoft | $446.34
-0.5% | 6/7/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $450.00 -> $500.00 | Low | View details for Oppenheimer rating of Microsoft (NASDAQ:MSFT) on 6/7/2024 |
ADUS Addus HomeCare | $119.30
+1.4% | 6/7/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $118.00 -> $130.00 | Low | View details for Oppenheimer rating of Addus HomeCare (NASDAQ:ADUS) on 6/7/2024 |
IFF International Flavors & Fragrances | $96.15
+1.4% | 6/7/2024 | Initiated by | Oppenheimer | - | Outperform | $116.00 | Low | View details for Oppenheimer rating of International Flavors & Fragrances (NYSE:IFF) on 6/7/2024 |
CPRX Catalyst Pharmaceuticals | $14.97
-0.2% | 6/6/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $29.00 -> $29.00 | Low | View details for Oppenheimer rating of Catalyst Pharmaceuticals (NASDAQ:CPRX) on 6/6/2024 |
LULU Lululemon Athletica | $313.23
+0.1% | 6/6/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $445.00 -> $445.00 | Low | View details for Oppenheimer rating of Lululemon Athletica (NASDAQ:LULU) on 6/6/2024 |
ADBE Adobe | $522.25
+0.7% | 6/6/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $660.00 -> $580.00 | Low | View details for Oppenheimer rating of Adobe (NASDAQ:ADBE) on 6/6/2024 |
BASE Couchbase | $16.86
-2.6% | 6/6/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $36.00 -> $30.00 | Low | View details for Oppenheimer rating of Couchbase (NASDAQ:BASE) on 6/6/2024 |
VTYX Ventyx Biosciences | $2.75
| 6/6/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $12.00 -> $10.00 | Low | View details for Oppenheimer rating of Ventyx Biosciences (NASDAQ:VTYX) on 6/6/2024 |
WMT Walmart | $67.60
+0.3% | 6/6/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $69.00 -> $75.00 | Low | View details for Oppenheimer rating of Walmart (NYSE:WMT) on 6/6/2024 |
COST Costco Wholesale | $870.75
+0.3% | 6/6/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $850.00 -> $905.00 | Low | View details for Oppenheimer rating of Costco Wholesale (NASDAQ:COST) on 6/6/2024 |
UBER Uber Technologies | $70.33
-0.2% | 6/5/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $90.00 -> $90.00 | Low | View details for Oppenheimer rating of Uber Technologies (NYSE:UBER) on 6/5/2024 |
GWRE Guidewire Software | $135.53
-0.2% | 6/5/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $130.00 -> $140.00 | Low | View details for Oppenheimer rating of Guidewire Software (NYSE:GWRE) on 6/5/2024 |
CRWD CrowdStrike | $389.51
-0.2% | 6/5/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $355.00 -> $400.00 | Low | View details for Oppenheimer rating of CrowdStrike (NASDAQ:CRWD) on 6/5/2024 |
CRNX Crinetics Pharmaceuticals | $44.29
-0.9% | 6/4/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $55.00 -> $74.00 | Low | View details for Oppenheimer rating of Crinetics Pharmaceuticals (NASDAQ:CRNX) on 6/4/2024 |
LVRO Lavoro | $5.28
-7.0% | 6/4/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $11.00 -> $9.00 | Low | View details for Oppenheimer rating of Lavoro (NASDAQ:LVRO) on 6/4/2024 |
$16T Crypto Plot From Elon Musk (Ad) Reports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market.
Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account."
Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run. Click here now to get your copy. |
RNAC Cartesian Therapeutics | $21.76
-6.7% | 6/4/2024 | Initiated by | Oppenheimer | - | Outperform | $50.00 | Low | View details for Oppenheimer rating of Cartesian Therapeutics (NASDAQ:RNAC) on 6/4/2024 |
FLUT Flutter Entertainment | $184.80
-2.1% | 6/4/2024 | Initiated by | Oppenheimer | - | Outperform | $240.00 | Low | View details for Oppenheimer rating of Flutter Entertainment (NYSE:FLUT) on 6/4/2024 |
IMVT Immunovant | $26.19
-2.3% | 6/3/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $50.00 -> $46.00 | Low | View details for Oppenheimer rating of Immunovant (NASDAQ:IMVT) on 6/3/2024 |
CRBP Corbus Pharmaceuticals | $43.81
-0.9% | 6/3/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $60.00 -> $80.00 | Low | View details for Oppenheimer rating of Corbus Pharmaceuticals (NASDAQ:CRBP) on 6/3/2024 |
AMSC American Superconductor | $25.18
+0.6% | 5/31/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $16.00 -> $23.00 | Low | View details for Oppenheimer rating of American Superconductor (NASDAQ:AMSC) on 5/31/2024 |
ASAN Asana | $11.87
-1.1% | 5/31/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $28.00 -> $23.00 | Low | View details for Oppenheimer rating of Asana (NYSE:ASAN) on 5/31/2024 |
MRVL Marvell Technology | $73.14
+1.8% | 5/31/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $80.00 -> $90.00 | Low | View details for Oppenheimer rating of Marvell Technology (NASDAQ:MRVL) on 5/31/2024 |
MDB MongoDB | $218.85
-2.2% | 5/31/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $480.00 -> $300.00 | Low | View details for Oppenheimer rating of MongoDB (NASDAQ:MDB) on 5/31/2024 |
XYL Xylem | $140.37
+0.6% | 5/31/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $147.00 -> $152.00 | Low | View details for Oppenheimer rating of Xylem (NYSE:XYL) on 5/31/2024 |
ZS Zscaler | $179.41
-2.7% | 5/31/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $290.00 -> $260.00 | Low | View details for Oppenheimer rating of Zscaler (NASDAQ:ZS) on 5/31/2024 |
LSEA Landsea Homes | $9.55
-0.1% | 5/31/2024 | Initiated by | Oppenheimer | - | Outperform | $14.00 | Low | View details for Oppenheimer rating of Landsea Homes (NASDAQ:LSEA) on 5/31/2024 |
BZH Beazer Homes USA | $28.16
-2.2% | 5/31/2024 | Initiated by | Oppenheimer | - | Outperform | $37.00 | Low | View details for Oppenheimer rating of Beazer Homes USA (NYSE:BZH) on 5/31/2024 |
BMEA Biomea Fusion | $4.85
-4.7% | 5/30/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $70.00 -> $60.00 | Low | View details for Oppenheimer rating of Biomea Fusion (NASDAQ:BMEA) on 5/30/2024 |
DKS DICK'S Sporting Goods | $227.70
+0.9% | 5/30/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $240.00 -> $270.00 | Low | View details for Oppenheimer rating of DICK’S Sporting Goods (NYSE:DKS) on 5/30/2024 |
CRM Salesforce | $231.80
+0.6% | 5/30/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $325.00 -> $280.00 | Low | View details for Oppenheimer rating of Salesforce (NYSE:CRM) on 5/30/2024 |
BOX BOX | $25.58
-0.4% | 5/29/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $35.00 -> $35.00 | Low | View details for Oppenheimer rating of BOX (NYSE:BOX) on 5/29/2024 |
BRZE Braze | $35.13
-0.8% | 5/29/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $75.00 -> $60.00 | Low | View details for Oppenheimer rating of Braze (NASDAQ:BRZE) on 5/29/2024 |
DKNG DraftKings | $43.25
+3.1% | 5/28/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $60.00 -> $60.00 | Low | View details for Oppenheimer rating of DraftKings (NASDAQ:DKNG) on 5/28/2024 |
LYV Live Nation Entertainment | $91.94
+1.7% | 5/24/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $120.00 -> $110.00 | Low | View details for Oppenheimer rating of Live Nation Entertainment (NYSE:LYV) on 5/24/2024 |
WDAY Workday | $207.69
-2.2% | 5/24/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $320.00 -> $300.00 | Low | View details for Oppenheimer rating of Workday (NASDAQ:WDAY) on 5/24/2024 |
NVDA NVIDIA | $135.58
+3.5% | 5/23/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $110.00 -> $110.00 | N/A | View details for Oppenheimer rating of NVIDIA (NASDAQ:NVDA) on 5/23/2024 |
SNOW Snowflake | $127.60
-2.3% | 5/23/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $220.00 -> $220.00 | Low | View details for Oppenheimer rating of Snowflake (NYSE:SNOW) on 5/23/2024 |
ADSK Autodesk | $244.12
+1.5% | 5/23/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $315.00 -> $275.00 | Low | View details for Oppenheimer rating of Autodesk (NASDAQ:ADSK) on 5/23/2024 |
MOD Modine Manufacturing | $97.84
+5.1% | 5/23/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $105.00 -> $110.00 | Low | View details for Oppenheimer rating of Modine Manufacturing (NYSE:MOD) on 5/23/2024 |
VIRX Viracta Therapeutics | $0.61
-6.1% | 5/23/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $13.00 -> $11.00 | Low | View details for Oppenheimer rating of Viracta Therapeutics (NASDAQ:VIRX) on 5/23/2024 |
UAA Under Armour | $6.96
+0.3% | 5/23/2024 | Downgraded by | Oppenheimer | - | Outperform -> Market Perform | | Low | View details for Oppenheimer rating of Under Armour (NYSE:UAA) on 5/23/2024 |
SCI Service Co. International | $71.71
-1.8% | 5/22/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $76.00 -> $79.00 | Low | View details for Oppenheimer rating of Service Co. International (NYSE:SCI) on 5/22/2024 |
COST Costco Wholesale | $870.75
+0.3% | 5/22/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $805.00 -> $850.00 | Low | View details for Oppenheimer rating of Costco Wholesale (NASDAQ:COST) on 5/22/2024 |
TRNS Transcat | $121.27
-0.7% | 5/22/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $125.00 -> $160.00 | Low | View details for Oppenheimer rating of Transcat (NASDAQ:TRNS) on 5/22/2024 |
TYL Tyler Technologies | $472.90
+1.2% | 5/22/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $500.00 -> $550.00 | Low | View details for Oppenheimer rating of Tyler Technologies (NYSE:TYL) on 5/22/2024 |
CMG Chipotle Mexican Grill | $3,427.82
+1.9% | 5/22/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $3,300.00 -> $3,485.00 | Low | View details for Oppenheimer rating of Chipotle Mexican Grill (NYSE:CMG) on 5/22/2024 |
GNRC Generac | $138.88
+2.2% | 5/22/2024 | Downgraded by | Oppenheimer | - | Outperform -> Market Perform | | Low | View details for Oppenheimer rating of Generac (NYSE:GNRC) on 5/22/2024 |
AME AMETEK | $170.99
+1.5% | 5/22/2024 | Upgraded by | Oppenheimer | - | Market Perform -> Outperform | $200.00 | Low | View details for Oppenheimer rating of AMETEK (NYSE:AME) on 5/22/2024 |
PANW Palo Alto Networks | $317.02
-0.8% | 5/21/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $330.00 -> $330.00 | Low | View details for Oppenheimer rating of Palo Alto Networks (NASDAQ:PANW) on 5/21/2024 |
SVRA Savara | $3.83
-1.0% | 5/21/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $9.50 -> $11.00 | Low | View details for Oppenheimer rating of Savara (NASDAQ:SVRA) on 5/21/2024 |
ALLO Allogene Therapeutics | $2.23
-3.0% | 5/21/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $14.00 -> $13.00 | Low | View details for Oppenheimer rating of Allogene Therapeutics (NASDAQ:ALLO) on 5/21/2024 |
ATXS Astria Therapeutics | $8.99
+1.8% | 5/21/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $29.00 -> $25.00 | Low | View details for Oppenheimer rating of Astria Therapeutics (NASDAQ:ATXS) on 5/21/2024 |
WIX Wix.com | $159.98
-0.8% | 5/21/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $160.00 -> $200.00 | Low | View details for Oppenheimer rating of Wix.com (NASDAQ:WIX) on 5/21/2024 |
SACH Sachem Capital | $2.76
-0.7% | 5/20/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $5.00 -> $4.50 | N/A | View details for Oppenheimer rating of Sachem Capital (NYSEAMERICAN:SACH) on 5/20/2024 |
NVDA NVIDIA | $135.58
+3.5% | 5/17/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $110.00 -> $110.00 | Low | View details for Oppenheimer rating of NVIDIA (NASDAQ:NVDA) on 5/17/2024 |
CFLT Confluent | $27.85
+0.2% | 5/17/2024 | Initiated by | Oppenheimer | - | Outperform | $37.00 | Low | View details for Oppenheimer rating of Confluent (NASDAQ:CFLT) on 5/17/2024 |
CAPR Capricor Therapeutics | $4.84
-2.4% | 5/17/2024 | Initiated by | Oppenheimer | - | Outperform | $14.00 | Low | View details for Oppenheimer rating of Capricor Therapeutics (NASDAQ:CAPR) on 5/17/2024 |
DE Deere & Company | $382.88
+1.0% | 5/16/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $456.00 -> $456.00 | Low | View details for Oppenheimer rating of Deere & Company (NYSE:DE) on 5/16/2024 |
HASI Hannon Armstrong Sustainable Infrastructure Capital | $30.99
+0.4% | 5/16/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $48.00 -> $48.00 | Low | View details for Oppenheimer rating of Hannon Armstrong Sustainable Infrastructure Capital (NYSE:HASI) on 5/16/2024 |
CSCO Cisco Systems | $45.97
+0.6% | 5/16/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $54.00 -> $58.00 | Low | View details for Oppenheimer rating of Cisco Systems (NASDAQ:CSCO) on 5/16/2024 |
EPIX ESSA Pharma | $4.66
-4.9% | 5/16/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $17.00 -> $17.00 | Low | View details for Oppenheimer rating of ESSA Pharma (NASDAQ:EPIX) on 5/16/2024 |
MNDY monday.com | $225.08
+1.2% | 5/16/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $240.00 -> $250.00 | Low | View details for Oppenheimer rating of monday.com (NASDAQ:MNDY) on 5/16/2024 |
ADI Analog Devices | $235.38
+1.3% | 5/16/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $215.00 -> $245.00 | Low | View details for Oppenheimer rating of Analog Devices (NASDAQ:ADI) on 5/16/2024 |
PACS PACS Group | $29.80
+1.2% | 5/15/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $31.00 -> $32.00 | Low | View details for Oppenheimer rating of PACS Group (NYSE:PACS) on 5/15/2024 |
STRO Sutro Biopharma | $3.04
-5.0% | 5/15/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $10.00 -> $10.00 | Low | View details for Oppenheimer rating of Sutro Biopharma (NASDAQ:STRO) on 5/15/2024 |
Nvidia needs this one obscure firm (Ad) In my new investigation, I detail why this is the single most important factor in the future of AI.
I explain what this Keystone technology is… why it’s so critical to the future of not just AI but mankind…  You must read this new presentation from Porter Stansberry. |
VECO Veeco Instruments | $48.17
+2.1% | 5/15/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $40.00 -> $45.00 | Low | View details for Oppenheimer rating of Veeco Instruments (NASDAQ:VECO) on 5/15/2024 |
VYGR Voyager Therapeutics | $8.16
-1.2% | 5/15/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $18.00 | Low | View details for Oppenheimer rating of Voyager Therapeutics (NASDAQ:VYGR) on 5/15/2024 |
WDAY Workday | $207.69
-2.2% | 5/15/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $350.00 -> $320.00 | Low | View details for Oppenheimer rating of Workday (NASDAQ:WDAY) on 5/15/2024 |
LAND Gladstone Land | $13.30
-1.4% | 5/15/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $20.00 -> $16.00 | Low | View details for Oppenheimer rating of Gladstone Land (NASDAQ:LAND) on 5/15/2024 |
JACK Jack in the Box | $51.20
-3.5% | 5/15/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $98.00 -> $75.00 | Low | View details for Oppenheimer rating of Jack in the Box (NASDAQ:JACK) on 5/15/2024 |
ALC Alcon | $89.32
+1.0% | 5/15/2024 | Upgraded by | Oppenheimer | - | Market Perform -> Outperform | $103.00 | N/A | View details for Oppenheimer rating of Alcon (NYSE:ALC) on 5/15/2024 |
AGYS Agilysys | $92.91
-1.3% | 5/14/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $95.00 -> $100.00 | Low | View details for Oppenheimer rating of Agilysys (NASDAQ:AGYS) on 5/14/2024 |
URGN UroGen Pharma | $16.87
-7.7% | 5/14/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $34.00 -> $32.00 | Low | View details for Oppenheimer rating of UroGen Pharma (NASDAQ:URGN) on 5/14/2024 |
SRPT Sarepta Therapeutics | $117.52
+0.6% | 5/14/2024 | Upgraded by | Oppenheimer | - | Market Perform -> Outperform | $180.00 | Low | View details for Oppenheimer rating of Sarepta Therapeutics (NASDAQ:SRPT) on 5/14/2024 |
FULC Fulcrum Therapeutics | $6.49
-7.3% | 5/14/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $16.00 -> $14.00 | Low | View details for Oppenheimer rating of Fulcrum Therapeutics (NASDAQ:FULC) on 5/14/2024 |
ACHV Achieve Life Sciences | $4.78
-4.0% | 5/13/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $18.00 -> $11.00 | Low | View details for Oppenheimer rating of Achieve Life Sciences (NASDAQ:ACHV) on 5/13/2024 |
CTOS Custom Truck One Source | $4.45
+1.4% | 5/13/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $8.00 -> $7.00 | Low | View details for Oppenheimer rating of Custom Truck One Source (NYSE:CTOS) on 5/13/2024 |
MNMD Mind Medicine (MindMed) | $7.32
-2.1% | 5/13/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $29.00 -> $20.00 | Low | View details for Oppenheimer rating of Mind Medicine (MindMed) (NASDAQ:MNMD) on 5/13/2024 |
SLNO Soleno Therapeutics | $41.90
-1.4% | 5/13/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $65.00 -> $59.00 | Low | View details for Oppenheimer rating of Soleno Therapeutics (NASDAQ:SLNO) on 5/13/2024 |
TYRA Tyra Biosciences | $17.20
-3.1% | 5/13/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $25.00 -> $28.00 | Low | View details for Oppenheimer rating of Tyra Biosciences (NASDAQ:TYRA) on 5/13/2024 |
VOR Vor Biopharma | $1.20
+2.6% | 5/13/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $15.00 -> $10.00 | Low | View details for Oppenheimer rating of Vor Biopharma (NYSE:VOR) on 5/13/2024 |
CRSP CRISPR Therapeutics | $60.57
-2.0% | 5/10/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $102.00 -> $95.00 | Low | View details for Oppenheimer rating of CRISPR Therapeutics (NASDAQ:CRSP) on 5/10/2024 |
ZURA Zura Bio | $3.38
-9.4% | 5/10/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $16.00 -> $21.00 | Low | View details for Oppenheimer rating of Zura Bio (NASDAQ:ZURA) on 5/10/2024 |
SPB Spectrum Brands | $91.03
+1.5% | 5/10/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $88.00 -> $115.00 | Low | View details for Oppenheimer rating of Spectrum Brands (NYSE:SPB) on 5/10/2024 |
EVCM EverCommerce | $9.87
-0.1% | 5/10/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $11.00 -> $12.00 | Low | View details for Oppenheimer rating of EverCommerce (NASDAQ:EVCM) on 5/10/2024 |
ARRY Array Technologies | $12.82
+3.4% | 5/10/2024 | Upgraded by | Oppenheimer | - | Market Perform -> Outperform | $20.00 | N/A | View details for Oppenheimer rating of Array Technologies (NASDAQ:ARRY) on 5/10/2024 |
TARS Tarsus Pharmaceuticals | $27.28
-5.4% | 5/9/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $59.00 -> $61.00 | Low | View details for Oppenheimer rating of Tarsus Pharmaceuticals (NASDAQ:TARS) on 5/9/2024 |
CYTK Cytokinetics | $51.94
-1.6% | 5/9/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $107.00 -> $106.00 | Low | View details for Oppenheimer rating of Cytokinetics (NASDAQ:CYTK) on 5/9/2024 |
VRDN Viridian Therapeutics | $12.18
-0.2% | 5/9/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $36.00 -> $31.00 | Low | View details for Oppenheimer rating of Viridian Therapeutics (NASDAQ:VRDN) on 5/9/2024 |
MCRB Seres Therapeutics | $0.71
+6.0% | 5/9/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $5.00 -> $4.00 | Low | View details for Oppenheimer rating of Seres Therapeutics (NASDAQ:MCRB) on 5/9/2024 |
BWAY BrainsWay | $6.09
+1.0% | 5/9/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $10.00 -> $11.00 | Low | View details for Oppenheimer rating of BrainsWay (NASDAQ:BWAY) on 5/9/2024 |
IAC IAC | $46.03
-2.4% | 5/9/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $65.00 -> $75.00 | Low | View details for Oppenheimer rating of IAC (NASDAQ:IAC) on 5/9/2024 |
APP AppLovin | $80.84
+3.0% | 5/9/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $85.00 -> $97.00 | Low | View details for Oppenheimer rating of AppLovin (NASDAQ:APP) on 5/9/2024 |
CCSI Consensus Cloud Solutions | $16.29
-6.2% | 5/9/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $29.00 -> $20.00 | Low | View details for Oppenheimer rating of Consensus Cloud Solutions (NASDAQ:CCSI) on 5/9/2024 |
CRBP Corbus Pharmaceuticals | $43.81
-0.9% | 5/8/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $58.00 -> $60.00 | Low | View details for Oppenheimer rating of Corbus Pharmaceuticals (NASDAQ:CRBP) on 5/8/2024 |
SAR Saratoga Investment | $22.97
-0.1% | 5/8/2024 | Downgraded by | Oppenheimer | - | Outperform -> Market Perform | $24.00 -> $23.00 | Low | View details for Oppenheimer rating of Saratoga Investment (NYSE:SAR) on 5/8/2024 |
PTON Peloton Interactive | $3.79
-4.1% | 5/7/2024 | Reiterated by | Oppenheimer | - | Outperform | | Low | View details for Oppenheimer rating of Peloton Interactive (NASDAQ:PTON) on 5/7/2024 |
FRPT Freshpet | $131.21
+1.2% | 5/7/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $120.00 -> $135.00 | Low | View details for Oppenheimer rating of Freshpet (NASDAQ:FRPT) on 5/7/2024 |
RXST RxSight | $57.07
+1.7% | 5/7/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $61.00 -> $72.00 | Low | View details for Oppenheimer rating of RxSight (NASDAQ:RXST) on 5/7/2024 |
ULTA Ulta Beauty | $382.59
-1.7% | 5/7/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $500.00 -> $475.00 | Low | View details for Oppenheimer rating of Ulta Beauty (NASDAQ:ULTA) on 5/7/2024 |
PLRX Pliant Therapeutics | $10.71
-4.4% | 5/7/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $47.00 -> $48.00 | Low | View details for Oppenheimer rating of Pliant Therapeutics (NASDAQ:PLRX) on 5/7/2024 |
CRVS Corvus Pharmaceuticals | $1.87
-3.1% | 5/7/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $7.00 -> $8.00 | Low | View details for Oppenheimer rating of Corvus Pharmaceuticals (NASDAQ:CRVS) on 5/7/2024 |
BOWL Bowlero | $13.73
+3.3% | 5/7/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $18.00 -> $15.00 | Low | View details for Oppenheimer rating of Bowlero (NYSE:BOWL) on 5/7/2024 |
ZETA Zeta Global | $15.60
-2.9% | 5/7/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $14.00 -> $18.00 | Low | View details for Oppenheimer rating of Zeta Global (NASDAQ:ZETA) on 5/7/2024 |
IART Integra LifeSciences | $29.00
+0.3% | 5/7/2024 | Downgraded by | Oppenheimer | - | Outperform -> Market Perform | | Low | View details for Oppenheimer rating of Integra LifeSciences (NASDAQ:IART) on 5/7/2024 |
WSC WillScot Mobile Mini | $38.12
-1.0% | 5/6/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $60.00 -> $53.00 | Low | View details for Oppenheimer rating of WillScot Mobile Mini (NASDAQ:WSC) on 5/6/2024 |
ACAD ACADIA Pharmaceuticals | $14.87
+0.2% | 5/6/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | $19.00 -> $19.00 | Low | View details for Oppenheimer rating of ACADIA Pharmaceuticals (NASDAQ:ACAD) on 5/6/2024 |
ALDX Aldeyra Therapeutics | $3.63
-1.4% | 5/6/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $10.00 -> $10.00 | Low | View details for Oppenheimer rating of Aldeyra Therapeutics (NASDAQ:ALDX) on 5/6/2024 |
DYN Dyne Therapeutics | $33.15
+4.3% | 5/6/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $47.00 -> $47.00 | Low | View details for Oppenheimer rating of Dyne Therapeutics (NASDAQ:DYN) on 5/6/2024 |
RLAY Relay Therapeutics | $7.03
-0.8% | 5/6/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $33.00 -> $25.00 | Low | View details for Oppenheimer rating of Relay Therapeutics (NASDAQ:RLAY) on 5/6/2024 |
ENSG The Ensign Group | $121.20
-0.8% | 5/6/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $130.00 -> $135.00 | Low | View details for Oppenheimer rating of The Ensign Group (NASDAQ:ENSG) on 5/6/2024 |
TRMB Trimble | $55.51
-0.4% | 5/6/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $72.00 -> $72.00 | Low | View details for Oppenheimer rating of Trimble (NASDAQ:TRMB) on 5/6/2024 |
PACS PACS Group | $29.80
+1.2% | 5/6/2024 | Initiated by | Oppenheimer | - | Outperform | $31.00 | Low | View details for Oppenheimer rating of PACS Group (NYSE:PACS) on 5/6/2024 |
CMMB Chemomab Therapeutics | $0.95
+11.8% | 5/6/2024 | Upgraded by | Oppenheimer | - | Market Perform -> Outperform | $6.00 | Low | View details for Oppenheimer rating of Chemomab Therapeutics (NASDAQ:CMMB) on 5/6/2024 |
AGCO AGCO | $102.29
-0.4% | 5/3/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $154.00 -> $145.00 | Low | View details for Oppenheimer rating of AGCO (NYSE:AGCO) on 5/3/2024 |
Nvidia needs this one obscure firm (Ad) In my new investigation, I detail why this is the single most important factor in the future of AI.
I explain what this Keystone technology is… why it’s so critical to the future of not just AI but mankind… You must read this new presentation from Porter Stansberry. |
APTV Aptiv | $70.62
-0.5% | 5/3/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $148.00 -> $145.00 | Low | View details for Oppenheimer rating of Aptiv (NYSE:APTV) on 5/3/2024 |
BWA BorgWarner | $33.02
-0.5% | 5/3/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $39.00 -> $40.00 | Low | View details for Oppenheimer rating of BorgWarner (NYSE:BWA) on 5/3/2024 |
CI The Cigna Group | $334.81
+0.3% | 5/3/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $370.00 -> $400.00 | Low | View details for Oppenheimer rating of The Cigna Group (NYSE:CI) on 5/3/2024 |
NET Cloudflare | $79.12
+1.9% | 5/3/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $122.00 -> $110.00 | Low | View details for Oppenheimer rating of Cloudflare (NYSE:NET) on 5/3/2024 |
COIN Coinbase Global | $235.95
-3.7% | 5/3/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $276.00 -> $282.00 | Low | View details for Oppenheimer rating of Coinbase Global (NASDAQ:COIN) on 5/3/2024 |
CTVA Corteva | $51.91
-0.2% | 5/3/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $67.00 -> $69.00 | Low | View details for Oppenheimer rating of Corteva (NYSE:CTVA) on 5/3/2024 |
THG The Hanover Insurance Group | $120.96
-1.9% | 5/3/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $150.00 -> $165.00 | Low | View details for Oppenheimer rating of The Hanover Insurance Group (NYSE:THG) on 5/3/2024 |
ITRI Itron | $102.86
-0.1% | 5/3/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $100.00 -> $110.00 | Low | View details for Oppenheimer rating of Itron (NASDAQ:ITRI) on 5/3/2024 |
KYMR Kymera Therapeutics | $31.20
-1.9% | 5/3/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $53.00 -> $52.00 | Low | View details for Oppenheimer rating of Kymera Therapeutics (NASDAQ:KYMR) on 5/3/2024 |
MRNA Moderna | $133.27
-3.4% | 5/3/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $142.00 -> $163.00 | Low | View details for Oppenheimer rating of Moderna (NASDAQ:MRNA) on 5/3/2024 |
SPXC SPX Technologies | $139.65
+1.1% | 5/3/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $134.00 -> $140.00 | Low | View details for Oppenheimer rating of SPX Technologies (NYSE:SPXC) on 5/3/2024 |
SPT Sprout Social | $33.55
-0.2% | 5/3/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $76.00 -> $43.00 | Low | View details for Oppenheimer rating of Sprout Social (NASDAQ:SPT) on 5/3/2024 |
WCC WESCO International | $163.73
-1.0% | 5/3/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $190.00 -> $200.00 | Low | View details for Oppenheimer rating of WESCO International (NYSE:WCC) on 5/3/2024 |
XYL Xylem | $140.37
+0.6% | 5/3/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $142.00 -> $147.00 | Low | View details for Oppenheimer rating of Xylem (NYSE:XYL) on 5/3/2024 |
ZBH Zimmer Biomet | $106.69
-0.3% | 5/3/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $150.00 -> $155.00 | Low | View details for Oppenheimer rating of Zimmer Biomet (NYSE:ZBH) on 5/3/2024 |
ARCC Ares Capital | $20.59
-0.6% | 5/2/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $21.00 -> $22.00 | Low | View details for Oppenheimer rating of Ares Capital (NASDAQ:ARCC) on 5/2/2024 |
TCPC BlackRock TCP Capital | $10.75
| 5/2/2024 | Target Lowered by | Oppenheimer | - | Market Perform -> Market Perform | $11.00 -> $10.00 | Low | View details for Oppenheimer rating of BlackRock TCP Capital (NASDAQ:TCPC) on 5/2/2024 |
CG The Carlyle Group | $39.56
+0.7% | 5/2/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $74.00 -> $68.00 | Low | View details for Oppenheimer rating of The Carlyle Group (NASDAQ:CG) on 5/2/2024 |
FSLR First Solar | $262.37
+0.4% | 5/2/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $269.00 -> $271.00 | Low | View details for Oppenheimer rating of First Solar (NASDAQ:FSLR) on 5/2/2024 |
GNRC Generac | $138.88
+2.2% | 5/2/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $140.00 -> $145.00 | Low | View details for Oppenheimer rating of Generac (NYSE:GNRC) on 5/2/2024 |
NGVT Ingevity | $43.49
-2.4% | 5/2/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $50.00 -> $58.00 | Low | View details for Oppenheimer rating of Ingevity (NYSE:NGVT) on 5/2/2024 |
INTA Intapp | $32.46
-3.7% | 5/2/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $50.00 -> $42.00 | Low | View details for Oppenheimer rating of Intapp (NASDAQ:INTA) on 5/2/2024 |
JCI Johnson Controls International | $69.12
-0.3% | 5/2/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $71.00 -> $70.00 | Low | View details for Oppenheimer rating of Johnson Controls International (NYSE:JCI) on 5/2/2024 |
NBIX Neurocrine Biosciences | $130.86
-3.3% | 5/2/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $200.00 -> $216.00 | Low | View details for Oppenheimer rating of Neurocrine Biosciences (NASDAQ:NBIX) on 5/2/2024 |
RSI Rush Street Interactive | $9.68
+0.1% | 5/2/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $9.00 -> $10.00 | Low | View details for Oppenheimer rating of Rush Street Interactive (NYSE:RSI) on 5/2/2024 |
UTHR United Therapeutics | $306.04
+3.0% | 5/2/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $375.00 -> $400.00 | Low | View details for Oppenheimer rating of United Therapeutics (NASDAQ:UTHR) on 5/2/2024 |
FRSH Freshworks | $12.10
-1.8% | 5/2/2024 | Downgraded by | Oppenheimer | - | Outperform -> Market Perform | | Low | View details for Oppenheimer rating of Freshworks (NASDAQ:FRSH) on 5/2/2024 |
NXPI NXP Semiconductors | $271.40
+0.1% | 5/1/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $250.00 -> $295.00 | Low | View details for Oppenheimer rating of NXP Semiconductors (NASDAQ:NXPI) on 5/1/2024 |
RSG Republic Services | $191.85
+0.1% | 5/1/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $202.00 -> $204.00 | Low | View details for Oppenheimer rating of Republic Services (NYSE:RSG) on 5/1/2024 |
DAN Dana | $12.55
-1.7% | 5/1/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $17.00 -> $18.00 | Low | View details for Oppenheimer rating of Dana (NYSE:DAN) on 5/1/2024 |
DENN Denny's | $6.43
-3.2% | 5/1/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $12.00 -> $11.00 | Low | View details for Oppenheimer rating of Denny’s (NASDAQ:DENN) on 5/1/2024 |
TREE LendingTree | $42.18
+0.5% | 5/1/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $45.00 -> $55.00 | Low | View details for Oppenheimer rating of LendingTree (NASDAQ:TREE) on 5/1/2024 |
AMZN Amazon.com | $182.81
-0.7% | 5/1/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $210.00 -> $220.00 | Low | View details for Oppenheimer rating of Amazon.com (NASDAQ:AMZN) on 5/1/2024 |
TMDX TransMedics Group | $145.96
+2.0% | 5/1/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $105.00 -> $125.00 | Low | View details for Oppenheimer rating of TransMedics Group (NASDAQ:TMDX) on 5/1/2024 |
LOVE Lovesac | $23.27
-4.1% | 5/1/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $60.00 -> $35.00 | Low | View details for Oppenheimer rating of Lovesac (NASDAQ:LOVE) on 5/1/2024 |
DPZ Domino's Pizza | $534.02
+0.3% | 4/30/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $530.00 -> $580.00 | Low | View details for Oppenheimer rating of Domino’s Pizza (NYSE:DPZ) on 4/30/2024 |
GS The Goldman Sachs Group | $457.30
+1.6% | 4/30/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $479.00 -> $517.00 | Low | View details for Oppenheimer rating of The Goldman Sachs Group (NYSE:GS) on 4/30/2024 |
JEF Jefferies Financial Group | $46.51
+3.4% | 4/30/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $54.00 -> $56.00 | Low | View details for Oppenheimer rating of Jefferies Financial Group (NYSE:JEF) on 4/30/2024 |
MS Morgan Stanley | $97.57
+0.5% | 4/30/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $101.00 -> $105.00 | Low | View details for Oppenheimer rating of Morgan Stanley (NYSE:MS) on 4/30/2024 |
BAC Bank of America | $40.00
+1.2% | 4/30/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $45.00 -> $46.00 | Low | View details for Oppenheimer rating of Bank of America (NYSE:BAC) on 4/30/2024 |
C Citigroup | $60.81
+1.2% | 4/30/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $87.00 -> $86.00 | Low | View details for Oppenheimer rating of Citigroup (NYSE:C) on 4/30/2024 |
CNC Centene | $66.39
-2.7% | 4/29/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $110.00 -> $110.00 | Low | View details for Oppenheimer rating of Centene (NYSE:CNC) on 4/29/2024 |
EXPE Expedia Group | $124.54
+0.4% | 4/29/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $175.00 -> $175.00 | Low | View details for Oppenheimer rating of Expedia Group (NASDAQ:EXPE) on 4/29/2024 |
ROP Roper Technologies | $560.10
+1.2% | 4/29/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $650.00 -> $650.00 | Low | View details for Oppenheimer rating of Roper Technologies (NYSE:ROP) on 4/29/2024 |
SFM Sprouts Farmers Market | $77.75
| 4/29/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Sprouts Farmers Market (NASDAQ:SFM) on 4/29/2024 |
UBER Uber Technologies | $70.33
-0.2% | 4/29/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $90.00 | Low | View details for Oppenheimer rating of Uber Technologies (NYSE:UBER) on 4/29/2024 |
URI United Rentals | $644.89
+4.1% | 4/29/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of United Rentals (NYSE:URI) on 4/29/2024 |
WT WisdomTree | $9.72
+2.9% | 4/29/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $11.00 -> $11.00 | Low | View details for Oppenheimer rating of WisdomTree (NYSE:WT) on 4/29/2024 |
LECO Lincoln Electric | $184.94
+0.3% | 4/29/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Lincoln Electric (NASDAQ:LECO) on 4/29/2024 |
BIIB Biogen | $223.65
-1.2% | 4/29/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $270.00 -> $270.00 | Low | View details for Oppenheimer rating of Biogen (NASDAQ:BIIB) on 4/29/2024 |
Elon Musk’s chilling warning for humanity (Ad) The 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern border is a travesty, but the 'invasion' I've found will have 10 times greater effects on our economy, and ultimately our way of life. Go here to see why. |
DASH DoorDash | $112.91
+0.2% | 4/29/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $140.00 -> $150.00 | Low | View details for Oppenheimer rating of DoorDash (NASDAQ:DASH) on 4/29/2024 |
ETSY Etsy | $57.67
-1.8% | 4/29/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $95.00 -> $80.00 | Low | View details for Oppenheimer rating of Etsy (NASDAQ:ETSY) on 4/29/2024 |
HCA HCA Healthcare | $340.65
+1.5% | 4/29/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $330.00 -> $345.00 | Low | View details for Oppenheimer rating of HCA Healthcare (NYSE:HCA) on 4/29/2024 |
CART Maplebear | $33.84
+1.8% | 4/29/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $36.00 -> $48.00 | Low | View details for Oppenheimer rating of Maplebear (NASDAQ:CART) on 4/29/2024 |
OSIS OSI Systems | $135.90
-0.2% | 4/29/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $157.00 -> $160.00 | Low | View details for Oppenheimer rating of OSI Systems (NASDAQ:OSIS) on 4/29/2024 |
POOL Pool | $337.89
-1.5% | 4/29/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $436.00 -> $416.00 | Low | View details for Oppenheimer rating of Pool (NASDAQ:POOL) on 4/29/2024 |
GOOGL Alphabet | $175.09
-1.2% | 4/26/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $185.00 -> $205.00 | Low | View details for Oppenheimer rating of Alphabet (NASDAQ:GOOGL) on 4/26/2024 |
TEAM Atlassian | $153.18
-2.2% | 4/26/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $300.00 -> $250.00 | Low | View details for Oppenheimer rating of Atlassian (NASDAQ:TEAM) on 4/26/2024 |
CSL Carlisle Companies | $421.87
+1.6% | 4/26/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $412.00 -> $430.00 | Low | View details for Oppenheimer rating of Carlisle Companies (NYSE:CSL) on 4/26/2024 |
CARR Carrier Global | $65.73
+0.9% | 4/26/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $63.00 -> $64.00 | Low | View details for Oppenheimer rating of Carrier Global (NYSE:CARR) on 4/26/2024 |
DOV Dover | $182.81
+2.0% | 4/26/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $187.00 -> $197.00 | Low | View details for Oppenheimer rating of Dover (NYSE:DOV) on 4/26/2024 |
RMD ResMed | $212.27
+0.9% | 4/26/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $205.00 -> $200.00 | Low | View details for Oppenheimer rating of ResMed (NYSE:RMD) on 4/26/2024 |
SPGI S&P Global | $435.85
+0.6% | 4/26/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $480.00 -> $482.00 | Low | View details for Oppenheimer rating of S&P Global (NYSE:SPGI) on 4/26/2024 |
TDOC Teladoc Health | $10.10
-0.1% | 4/26/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $26.00 -> $21.00 | Low | View details for Oppenheimer rating of Teladoc Health (NYSE:TDOC) on 4/26/2024 |
TPH Tri Pointe Homes | $37.08
-2.1% | 4/26/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $41.00 -> $46.00 | Low | View details for Oppenheimer rating of Tri Pointe Homes (NYSE:TPH) on 4/26/2024 |
WM Waste Management | $207.89
+0.7% | 4/26/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $221.00 -> $228.00 | Low | View details for Oppenheimer rating of Waste Management (NYSE:WM) on 4/26/2024 |
TYL Tyler Technologies | $472.90
+1.2% | 4/26/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $480.00 -> $500.00 | Low | View details for Oppenheimer rating of Tyler Technologies (NYSE:TYL) on 4/26/2024 |
VRT Vertiv | $95.32
+6.4% | 4/25/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $96.00 -> $98.00 | Low | View details for Oppenheimer rating of Vertiv (NYSE:VRT) on 4/25/2024 |
CMG Chipotle Mexican Grill | $3,427.82
+1.9% | 4/25/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $2,825.00 -> $3,300.00 | Low | View details for Oppenheimer rating of Chipotle Mexican Grill (NYSE:CMG) on 4/25/2024 |
CYH Community Health Systems | $3.48
-0.6% | 4/25/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $5.50 -> $4.50 | Low | View details for Oppenheimer rating of Community Health Systems (NYSE:CYH) on 4/25/2024 |
HUM Humana | $349.55
-1.6% | 4/25/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $415.00 -> $370.00 | Low | View details for Oppenheimer rating of Humana (NYSE:HUM) on 4/25/2024 |
META Meta Platforms | $499.49
-1.4% | 4/25/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $585.00 -> $500.00 | N/A | View details for Oppenheimer rating of Meta Platforms (NASDAQ:META) on 4/25/2024 |
ENPH Enphase Energy | $119.01
-1.5% | 4/24/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $133.00 -> $134.00 | Low | View details for Oppenheimer rating of Enphase Energy (NASDAQ:ENPH) on 4/24/2024 |
INCY Incyte | $61.44
-2.0% | 4/24/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $92.00 -> $84.00 | Low | View details for Oppenheimer rating of Incyte (NASDAQ:INCY) on 4/24/2024 |
NBIX Neurocrine Biosciences | $130.86
-3.3% | 4/24/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $200.00 -> $200.00 | Low | View details for Oppenheimer rating of Neurocrine Biosciences (NASDAQ:NBIX) on 4/24/2024 |
NEP NextEra Energy Partners | $28.06
+2.6% | 4/24/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of NextEra Energy Partners (NYSE:NEP) on 4/24/2024 |
PNR Pentair | $79.59
+2.0% | 4/24/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $88.00 -> $90.00 | Low | View details for Oppenheimer rating of Pentair (NYSE:PNR) on 4/24/2024 |
PHM PulteGroup | $111.14
-2.7% | 4/24/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $138.00 -> $143.00 | Low | View details for Oppenheimer rating of PulteGroup (NYSE:PHM) on 4/24/2024 |
TSLA Tesla | $184.86
-1.4% | 4/24/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Tesla (NASDAQ:TSLA) on 4/24/2024 |
TXN Texas Instruments | $196.25
+0.7% | 4/24/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Texas Instruments (NASDAQ:TXN) on 4/24/2024 |
UPS United Parcel Service | $134.20
-1.2% | 4/24/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $153.00 -> $157.00 | Low | View details for Oppenheimer rating of United Parcel Service (NYSE:UPS) on 4/24/2024 |
V Visa | $273.62
+0.9% | 4/24/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $297.00 -> $299.00 | Low | View details for Oppenheimer rating of Visa (NYSE:V) on 4/24/2024 |
MSCI MSCI | $476.52
-1.7% | 4/24/2024 | Reiterated by | Oppenheimer | - | Outperform -> Market Perform | | Low | View details for Oppenheimer rating of MSCI (NYSE:MSCI) on 4/24/2024 |
EA Electronic Arts | $138.13
+0.4% | 4/23/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $150.00 -> $150.00 | Low | View details for Oppenheimer rating of Electronic Arts (NASDAQ:EA) on 4/23/2024 |
GANX Gain Therapeutics | $1.28
-3.0% | 4/23/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $9.00 | Low | View details for Oppenheimer rating of Gain Therapeutics (NASDAQ:GANX) on 4/23/2024 |
TTWO Take-Two Interactive Software | $155.37
-1.3% | 4/23/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $185.00 | Low | View details for Oppenheimer rating of Take-Two Interactive Software (NASDAQ:TTWO) on 4/23/2024 |
VZ Verizon Communications | $40.08
+1.6% | 4/23/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $48.00 -> $48.00 | Low | View details for Oppenheimer rating of Verizon Communications (NYSE:VZ) on 4/23/2024 |
CHD Church & Dwight | $109.91
+0.6% | 4/23/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $110.00 -> $120.00 | Low | View details for Oppenheimer rating of Church & Dwight (NYSE:CHD) on 4/23/2024 |
ATRC AtriCure | $21.20
+6.7% | 4/23/2024 | Upgraded by | Oppenheimer | - | Market Perform -> Outperform | $32.00 | Low | View details for Oppenheimer rating of AtriCure (NASDAQ:ATRC) on 4/23/2024 |
TARA Protara Therapeutics | $2.34
-8.2% | 4/22/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $26.00 -> $30.00 | Low | View details for Oppenheimer rating of Protara Therapeutics (NASDAQ:TARA) on 4/22/2024 |
WT WisdomTree | $9.72
+2.9% | 4/22/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $12.00 -> $11.00 | Low | View details for Oppenheimer rating of WisdomTree (NYSE:WT) on 4/22/2024 |
KYMR Kymera Therapeutics | $31.20
-1.9% | 4/22/2024 | Initiated by | Oppenheimer | - | Outperform | $53.00 | Low | View details for Oppenheimer rating of Kymera Therapeutics (NASDAQ:KYMR) on 4/22/2024 |
GILD Gilead Sciences | $63.15
-1.7% | 4/19/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $105.00 | Low | View details for Oppenheimer rating of Gilead Sciences (NASDAQ:GILD) on 4/19/2024 |
NFLX Netflix | $685.67
+1.5% | 4/19/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $725.00 | Low | View details for Oppenheimer rating of Netflix (NASDAQ:NFLX) on 4/19/2024 |
SBUX Starbucks | $80.20
-1.4% | 4/19/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Starbucks (NASDAQ:SBUX) on 4/19/2024 |
BIIB Biogen | $223.65
-1.2% | 4/19/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $290.00 -> $270.00 | Low | View details for Oppenheimer rating of Biogen (NASDAQ:BIIB) on 4/19/2024 |
EFX Equifax | $241.72
+1.1% | 4/19/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $291.00 -> $272.00 | Low | View details for Oppenheimer rating of Equifax (NYSE:EFX) on 4/19/2024 |
USB U.S. Bancorp | $39.29
+0.5% | 4/18/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $55.00 -> $54.00 | Low | View details for Oppenheimer rating of U.S. Bancorp (NYSE:USB) on 4/18/2024 |
XYL Xylem | $140.37
+0.6% | 4/18/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $133.00 -> $142.00 | Low | View details for Oppenheimer rating of Xylem (NYSE:XYL) on 4/18/2024 |
SAGE Sage Therapeutics | $10.75
-4.6% | 4/18/2024 | Target Lowered by | Oppenheimer | - | Market Perform -> Market Perform | $25.00 -> $17.00 | Low | View details for Oppenheimer rating of Sage Therapeutics (NASDAQ:SAGE) on 4/18/2024 |
TRNS Transcat | $121.27
-0.7% | 4/18/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $120.00 -> $125.00 | Low | View details for Oppenheimer rating of Transcat (NASDAQ:TRNS) on 4/18/2024 |
AOS A. O. Smith | $84.21
+0.6% | 4/18/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of A. O. Smith (NYSE:AOS) on 4/18/2024 |
WMS Advanced Drainage Systems | $177.06
+1.3% | 4/18/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $172.00 -> $180.00 | Low | View details for Oppenheimer rating of Advanced Drainage Systems (NYSE:WMS) on 4/18/2024 |
AVNT Avient | $43.68
+0.6% | 4/18/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $45.00 -> $49.00 | Low | View details for Oppenheimer rating of Avient (NYSE:AVNT) on 4/18/2024 |
CSL Carlisle Companies | $421.87
+1.6% | 4/18/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $405.00 -> $412.00 | Low | View details for Oppenheimer rating of Carlisle Companies (NYSE:CSL) on 4/18/2024 |
CARR Carrier Global | $65.73
+0.9% | 4/18/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $63.00 | Low | View details for Oppenheimer rating of Carrier Global (NYSE:CARR) on 4/18/2024 |
CAT Caterpillar | $324.87
+0.8% | 4/18/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Caterpillar (NYSE:CAT) on 4/18/2024 |
DOV Dover | $182.81
+2.0% | 4/18/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $177.00 -> $187.00 | Low | View details for Oppenheimer rating of Dover (NYSE:DOV) on 4/18/2024 |
IEX IDEX | $202.31
+1.0% | 4/18/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $245.00 -> $252.00 | Low | View details for Oppenheimer rating of IDEX (NYSE:IEX) on 4/18/2024 |
JCI Johnson Controls International | $69.12
-0.3% | 4/18/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $66.00 -> $71.00 | Low | View details for Oppenheimer rating of Johnson Controls International (NYSE:JCI) on 4/18/2024 |
